Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-β-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-β-D-erythro-pentofuranosyl)cytidine

Cancer Research

Volumn 61, Issue 1, 2001, Pages 178-185

  Niitsu, N ^a   Ishii, Y ^a   Matsuda, A ^a   Honma, Y ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 DEOXY 2 METHYLENE BETA DEXTRO ERYTHRO PENTOFURANOSYL)CYTIDINE; CYTARABINE; CYTIDINE DEAMINASE; CYTIDINE DERIVATIVE; RETINOIC ACID; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL STRAIN U937; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA REMISSION; PRIORITY JOURNAL; RELAPSE;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIFFERENTIATION; CELL DIVISION; CYTARABINE; CYTIDINE DEAMINASE; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; GROWTH INHIBITORS; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TRETINOIN; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0035143427     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Molecular analysis of breakpoint cluster region on chromosome 17
2. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML
3. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia
4. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
5. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid)
6. The "retinoic acid syndrome" in acute promyelocytic leukemia
7. Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid
8. Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications
9. Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
10. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents
11. Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid
12. Design, synthesis, and antineoplastic activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative
13. Nucleosides and nucleotides. 97. Synthesis of new broad-spectrum antineoplastic nucleosides, 2'deoxy-2'-methylidenecytidine (DMDC) and its derivatives
14. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative
15. Cell kill kinetics of an antineoplastic nucleoside, 1-(2-deoxy-2-methylene-βD-erythro-pentofuranosyl)cytosine
16. 2′-Deoxy-2′-methylenecytidine and 2′-deoxy-2′2′-difluorocytidine-5′-diphosphat es, potent mechanism-based inhibitors of ribonucleotide reductase
17. 2′-Deoxy-2′-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture
18. Design of new types of antitumor nucleosides
19. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
20. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in newly established acute promyelocytic leukemia cell line with t(15;17)
21. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine
22. AMLla but not AMLlb inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells
23. Role of CD14 expression in the differentiation apoptosis switch in human monocytic leukemia cells treated with lα,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factorβ
24. Hemin enhances the sensitivity of erythroleukemia cells to 1-β-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity
25. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinasedependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest
26. Retinobenzoic acids. 1. Structure-activity relationship of aromatic amides with retinoidal activity
27. Treatment with a new synthetic retinoid, Am-80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoid acid
28. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid
29. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR
30. Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid
31. Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60
32. Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture
33. Metabolism of pyrimidine analogues and their nucleosides
34. Clinical counterpoint; vitamin D: New actions, new analogs, new therapeutic potential
35. 1α, 25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells
36. 1 α,25-Dihydroxyvitamin D3 and 1 α-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells
37. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: In vitro and in vivo studies
38. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine
39. Studies of the enzymatic deamination of 1-β-D-arabinofuranosylcytosine-1. Enzyme distribution and species specificity
40. Ara-C metabolism; implications for drug resistance and drug interactions
41. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate
42. Small dose of Ara-C in the treatment of acute myeloid leukemia; differentiation of myeloid leukemia cells?
43. Phase I study on DMDC
44. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR α/PML proteins
45. Arsenic-induced, P. M. L. targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
46. The antiproliferative activity of DMDC is modulated by inhibition of cytidine deaminase
47. Phase I evaluation of tetrahydrouridine combined with 1-β-D-arabinofuranosylcytosine
48. Therapy of refractory/relapsed acute leukemia with 1-β-D-arabinofuranosylcytosine plus tetrahydrouridine (an inhibitor of cytidine deaminase): A pilot study